2022 Agenda

Welcome and Chairperson’s Opening Remarks

Dustin Chernick, Director of Scientific Communications
Gilead Sciences

Keynote Address: State of the Profession and the Future of Publication Planning

• Survey publication industry trends to prepare for post pandemic outcomes
• Predict how the role of publications professional will continue to evolve
• Explore the current issues before the medical and scientific publications industry to shape frameworks that address needs and advance the industry in a positive direction 

Kris Schuler, Senior Director, Publications Team Leader, Global Scientific Communications

Pfizer Biopharmaceuticals Group

What's New for 2022: Preparing for Future Directions

• Understand how upcoming innovations in good publications practice were developed
• Discuss new developments in the field from multiple perspectives
• Learn best practices for complying with April 2021 changes to the Consolidated Standards of Reporting Trials (CONSORT) guidelines

 
Lisa DeTora, Associate Professor and Director of STEM Writing
Hofstra University

Leslie Citrome, Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Editor Emeritus
International Journal of Clinical Practice

Shweta Rane, Global Medical Director
Biogen

Best Practices for Inclusivity and Diversity in Clinical Trials

• Explore integration of diverse patient data and perspectives into clinical development and data dissemination plans
• Discuss how to best communicate with the patient community to drive the best and truly equitable results

Shweta Rane, Global Medical Director
Biogen

Lauren Deluca, Executive Director & Founding President
Chronic Illness Advocacy & Awareness Group

Finding Consensus on Enriched Content and Plain Language Summaries (PLS)

• Explore how publications enrichments and other developments in our field can be best applied to increase publication discoverability as well as a deeper understanding of the material
• Survey perspectives on PLS, their usage, and how to avoid crossing the line into promotional material
• Explore how to improve search functions and discoverability as well as construct metrics to measure reach of the article and PLS’s impact

Moderator:

Monica Ramchandani, Senior Director, Clinical Development, Medical Writing and Publications
Gilead Sciences

Panelists:

Kelly Soldavin, Senior Editor
Taylor & Francis

Kris Schuler, Senior Director, Publications Team Leader, Global Scientific Communications
Pfizer Biopharmaceuticals Group

Caroline Halford, Digital Publishing Manager
Springer Healthcare

Seizing Opportunities Beyond Typical Medical Publications – Influencing without Authority

• Discuss types of publications that are developed via data-generation functions that may not be in Medical Affairs/Clinical Development (ie, health economics and outcomes research [HEOR], real-world evidence [RWE], case studies, guidelines, registries, meta-analyses)
• Explore challenges and where in the organization these types of publications reside (ie, who oversees the budget, timelines)
• Learn best practices on how to work with internal and external colleagues on these types of publications

Moderator:
Donna Simcoe, Principal, Medical Publication Consultant
Simcoe Consultants

Panelists:
Charlotte Singh, Director, Cardiovascular/Established Products Publications Lead
Sanofi US

Ana Bozas, Director Medical Communications
Pear Therapeutics

Authorship and Inclusivity

• Ensure that the inclusivity, equity, and diversity in your clinical trials continues through the publication process, from authorship on down to data dissemination plans
• Gain tactics to bring diversity across the publication process and gain equity and equality in representation from start to finish
• Discuss next steps for policy development, transparency, and accessibility to enable transgender authors to correct their names in the published record

Moderator:
Sissy Easo-Joseph, Director, Scientific Communications, Migraine and Headache, Global Medical Affairs
Teva Pharmaceuticals

Panelists:
Chandra Abbott, Senior Director and Head, Scientific Communications and Operations- Medical Affairs
Biohaven Pharmaceuticals

Kerri Hebard-Massey, Associate Director
Ultragenyx Pharmaceuticals

Chairperson’s Day One Summary Remarks and Lead Into Breakout Discussions

Dustin Chernick, Director of Scientific Communications
Gilead Sciences

Choose Your Own Adventure Breakouts

During this breakout session, turn your camera and mic on and join up to three, intimately sized discussion groups, facilitated by the day’s speakers. Address your unique concerns and network with peers and TIPPA presenters alike:

Facilitated Discussion Topics:

Breakout 1: The Future of Publication Planning
Payal Patel, Senior Director, Medical Communications and Medical Information
Genmab

Doug Wicks, Publication Lead, Specialty & Primary Care (S&PC) Publications
GlaxoSmithKline

Breakout 2: Best Practices for Inclusivity and Diversity in Clinical Trials
Shweta Rane, Global Medical Director
Biogen

Breakout 3: Finding Consensus on Enriched Content and PLS
Monica Ramchandani, Senior Director, Clinical Development, Medical Writing and Publications
Gilead Sciences

Breakout 4: Seizing Opportunities Beyond Typical Medical Publications – Influencing without Authority
Charlotte Singh, Director, Cardiovascular/Established Products Publications Lead
Sanofi US

Breakout 5: Authorship and Inclusivity
Chandra Abbott, Senior Director and Head, Scientific Communications and Operations- Medical Affairs
Biohaven Pharmaceuticals